Oxford Finance’s Healthcare Leveraged Lending Group Provides 2023 Mid-Year Update
Summary
May 2023: Oxford acted as the administrative agent in the funding of a senior credit facility to finance the majority recapitalization of a leading outsourced electronics-focused design, engineering, and product manufacturer to the medical device and life sciences industries by EW Healthcare Partners. February 2023: Oxford acted as the administrative agent in the funding of a senior credit facility to finance the recapitalization of a leading provider of medical communications solutions to global life sciences companies by NMS Capital. February 2023: Oxford acted as the administrative agent in the funding of a senior credit facility for the acquisition of a leading provider of high-quality consumables, parts, equipment and maintenance and repair services to anatomic pathology & histology labs by Water Street Healthcare Partners. January 2023: Oxford acted as the administrative agent in the funding of a senior credit facility to finance an add-on acquisition by a Mountaingate Capital-backed provider of disposable medical devices and wound care products. January 2023: Oxford acted as the administrative agent in the funding of a senior credit facility to finance a significant partnership with a gastroenterology business by a multi-specialty physician services platform in the Western US backed by Triton Pacific Capital Partners.